SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.98+1.1%Nov 5 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: A.J. Mullen11/13/2022 6:23:33 PM
3 Recommendations

Recommended By
Lance Bredvold
OldAIMGuy
Steve Lokness

  Read Replies (1) of 52153
 
Japanese insurer claims Palantir gives it “godlike powers.” It’s preparing to offer insurance against dementia to the nation with the oldest population. It’ll offer to pay out when dementia symptoms occur and provide incentives to individuals to delay the onset if they modify their behaviour – diet, sleep, exercise, etc. Nothing wrong with that, but
Palantir’s technology has so far enabled the insurer to analyse correlations of data and create a model to suggest improvements to care plans for each resident. Okumura hoped that these “big data” skills could now serve its core insurance business, helping the company to develop an insurance package that “avoids risks”. ft.com

Insurance works by pooling risk. Stratification could make insurance unavailable or cost-prohibitive for those with the greatest need.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News